Immune Tech提供全面的人源化抗体服务，包括靶点筛选，表达和免疫，高度复杂的单克隆抗体筛选，抗体测序和特性鉴定，生物学和其它检测，抗体制备细胞系建立，基于动物模型的药效研究等。Immune Tech的抗体开发团队由在治疗抗体和疫苗开发领域拥有广泛经验的多名资深科学家组成，他们将全程参与治疗药物的开发。
以下是我们科学家团队发表的学术论文：
1. Science 16 September 2011: Vol. 333 no. 6049 pp. 1593-1602.
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed byStructures and Deep Sequencing.
2. Science 13 August 2010: Vol. 329 no. 5993 pp. 811-817.
Structural Basis for Broad and Potent Neutralization of HIV-1 byAntibody VRC01.
3. Science 13 August 2010: Vol. 329 no. 5993 pp. 856-861.
Rational Design of Envelope Identifies Broadly Neutralizing HumanMonoclonal Antibodies to HIV-1.
4. Science 27 August 2010: Vol. 329 no. 5995 pp. 1060-1064.
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination.
5. Nature 480, 336–343 15 December 2011.
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizingantibody PG9.
6. Nature Medicine 16, 334–338 2010.
A virus-like particle vaccine for epidemic Chikungunya virus protectsnonhuman primates against infection.
7. Nature 445, 732-737 15 February 2007.
Structural definition of a conserved neutralization epitope on HIV-1 gp120.
产品描述
